A Study on the Inhibitory Potential of Dpp-Iv Enzyme by Lobeline through In silico and In vivo Approaches

References (23)

1. 1 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 [DOI]
2. 2 Molecular Properties That Influence the Oral Bioavailability of Drug Candidates [DOI]
3. 3 Dipeptidyl-Peptidase IV from Bench to Bedside: An Update on Structural Properties, Functions, and Clinical Aspects of the Enzyme DPP IV [DOI]
4. 4 GIP and GLP‐1, the two incretin hormones: Similarities and differences [DOI]
5. 5 iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis [DOI]
6. 6 Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects [DOI]
7. 7 Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone [DOI]
8. 8 Vincristine and Vinblastine Anticancer Catharanthus Alkaloids: Pharmacological Applications and Strategies for Yield Improvement [DOI]
9. 9 Possible Mechanisms of Morphine Analgesia [DOI]
10. 10 Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors [DOI]
11. 11 Review of sitagliptin phosphate: a novel treatment for type 2 diabetes [DOI]
12. 12 Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors [DOI]
13. 13 Antihyperglycemic activity with DPP-IV inhibition of alkaloids from seed extract of Castanospermum australe: Investigation by experimental validation and molecular docking [DOI]
14. 14 Dipeptidyl Peptidase- IV Inhibitory Activity of Berberis aristata
15. 15 Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus [DOI]
16. 16 Experimental Models on Diabetes: A Comprehensive Review [DOI]
17. 17 Primary Virtual and in vitro Bioassay Screening of Natural Inhibitors from Flavonoids against COX-2 [DOI]
18. 18 Indole Alkaloids as New Leads for the Design and Development of Novel DPP-IV Inhibitors for the Treatment of Diabetes [DOI]
19. 19 Molecular Docking Study of Certain Plant Alkaloid Derivatives as Inhibitors of Various Drug Targets of Alzheimer’s Disease [DOI]
20. 20 AN IN SILICO STUDY OF NOVEL FLUOROQUINOLONES AS INHIBITORS OF DNA GYRASE OF STAPHYLOCOCCUS AUREUS
21. 21 Insilico Design of a Ligand for Dpp IV in Type II Diabetes
22. 22 Chemical constituents in leaves of Morus atropurpurea and their α-glucosidase activity
23. 23 THE MODE OF ACTION OF CERTAIN DRUGS WHICH STIMULATE RESPIRATION [DOI]

Cited by 8

Showing 1 of 8 known citations — external sources report more than can currently be individually listed.

Related research

• Novel Biomarkers for Early Detection and Metabolic Profiling in Diabetes and Prediabetes — shares topic coverage
• Association of Proteobacteria and Bacteriodetes with Obese Related Type-2 Diabetes Mellitus — shares topic coverage
• Echocardiographic Changes in Controlled Type 2 Diabetes Mellitus with Reference to Body Mass Index and Waist Hip Ratio — shares topic coverage
• Asymptomatic Cardiovascular Disorders in a Cohort of Clinically Stable Type 2 Diabetes Mellitus Patients in South Eastern Nigeria: A Cross Sectional Study — shares topic coverage
• Phytochemical and Antibacterial Investigation of Leaf Extracts of Vernonia amygdalina — shares topic coverage